InnoCyte GmbH Finds Further Investors
Advertisement
InnoCyte GmbH has won three renowned investors for their cause: In a first round of financing, High-Tech Gründerfonds (HTGF), the Mittelständische Beteiligungsgesellschaft (MBG) – within the framework of the Seedfonds Baden-Württemberg – and Fraunhofer Venture have increased the capital of the young GmbH by a high six-figure amount. The goal is to push growth and further advance the technology.
InnoCyte GmbH has developed a technology that standardizes, automates, accelerates and therefore significantly simplifies and reduces the cost of producing biological cells. The cell production as such is a key process in biological and medical research, for example in the development of medication („pharma screening“) or when creating artificial tissue („tissue engineering“).